Buy, Sell Or Hold: Ashok Leyland, Lupin, Glenmark Pharma, Coal India, NTPC— Ask Profit

Should you buy shares of EIH Ltd. at the current market price? Is Ashok Leyland Ltd. a good choice from a long-term perspective? Should you keep holding shares of KPIT Technologies Ltd.? Is it the right time to exit Lupin Ltd. and book profits?

Ravi Singh of Religare Broking answered these investor queries and more on NDTV Profit's Ask Profit show.

Ravi: Book Profit

• The long-term outlook for this stock is bearish, with potential to reach Rs 300-280 levels.

• Book profits on this stock at the current market price.

• Consider buying ITC at the current price, as it shows strong technical support, and the correction phase appears to be over.

Ravi: Strong fundamentals

• The stock has strong fundamentals and is showing consolidation.

• A good investment point is when the stock reaches Rs 200-210 levels, offering potential for increased profit.

• The long-term target for the stock is Rs 240, but it may take eight to ten months to achieve.

Ravi: Hold

• Hold this stock with a stop loss set at Rs 1,200. Reconsider the stock if it breaches or reaches this level.

• An upward trend is expected for this stock, but it may take another six to eight months.

Ravi: Hold

• Hold on to Lupin, as it appears strong.

• The fundamentals of the stock look positive, with a target of Rs 2,400 in the next six months.

Ravi: Hold

• The stock is currently in a profit booking phase, but the overall structure looks promising.

• There's no need to panic; you can still achieve more returns on this stock.

• Consider adding Cipla and Sun Pharma to your portfolio if needed.

Ravi: Have Potential

• Both stocks have the potential to perform well.

• Investors can allocate 70% of their funds to these stocks.

• If Coal India drops below Rs 350, consider averaging.

• Rs 290 is an optimal level for NTPC.